- Home
- CPBI vs ATNM Comparison
CPBI vs ATNM Comparison
Compare CPBI & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- ATNM
- Stock Information
- Founded
- CPBI 2023
- ATNM 2000
- Country
- CPBI United States
- ATNM United States
- Employees
- CPBI N/A
- ATNM N/A
- Industry
- CPBI
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- ATNM Health Care
- Exchange
- CPBI Nasdaq
- ATNM Nasdaq
- Market Cap
- CPBI 56.9M
- ATNM 51.5M
- IPO Year
- CPBI N/A
- ATNM N/A
- Fundamental
- Price
- CPBI $15.05
- ATNM $1.36
- Analyst Decision
- CPBI
- ATNM Strong Buy
- Analyst Count
- CPBI 0
- ATNM 3
- Target Price
- CPBI N/A
- ATNM $4.67
- AVG Volume (30 Days)
- CPBI 4.5K
- ATNM 508.7K
- Earning Date
- CPBI 01-01-0001
- ATNM 08-04-2025
- Dividend Yield
- CPBI N/A
- ATNM N/A
- EPS Growth
- CPBI N/A
- ATNM N/A
- EPS
- CPBI 0.96
- ATNM N/A
- Revenue
- CPBI $18,899,000.00
- ATNM N/A
- Revenue This Year
- CPBI N/A
- ATNM N/A
- Revenue Next Year
- CPBI N/A
- ATNM N/A
- P/E Ratio
- CPBI $15.79
- ATNM N/A
- Revenue Growth
- CPBI 9.64
- ATNM N/A
- 52 Week Low
- CPBI $10.09
- ATNM $1.03
- 52 Week High
- CPBI $15.50
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- CPBI 46.81
- ATNM 43.05
- Support Level
- CPBI $14.88
- ATNM $1.41
- Resistance Level
- CPBI $14.99
- ATNM $1.95
- Average True Range (ATR)
- CPBI 0.13
- ATNM 0.12
- MACD
- CPBI -0.00
- ATNM -0.02
- Stochastic Oscillator
- CPBI 8.57
- ATNM 11.93
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.